- Home
- RADX vs STEC Comparison
RADX vs STEC Comparison
Compare RADX & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- STEC
- Stock Information
- Founded
- RADX 2021
- STEC 2006
- Country
- RADX Australia
- STEC Hong Kong
- Employees
- RADX N/A
- STEC N/A
- Industry
- RADX
- STEC
- Sector
- RADX
- STEC
- Exchange
- RADX NYSE
- STEC NYSE
- Market Cap
- RADX 32.5M
- STEC 63.8M
- IPO Year
- RADX N/A
- STEC 2021
- Fundamental
- Price
- RADX $4.77
- STEC $0.72
- Analyst Decision
- RADX Strong Buy
- STEC
- Analyst Count
- RADX 3
- STEC 0
- Target Price
- RADX $15.00
- STEC N/A
- AVG Volume (30 Days)
- RADX 18.6K
- STEC 12.8K
- Earning Date
- RADX 02-26-2025
- STEC 08-05-2025
- Dividend Yield
- RADX N/A
- STEC N/A
- EPS Growth
- RADX N/A
- STEC N/A
- EPS
- RADX N/A
- STEC N/A
- Revenue
- RADX $204,609.00
- STEC $10,672,000.00
- Revenue This Year
- RADX N/A
- STEC $9,392.20
- Revenue Next Year
- RADX N/A
- STEC N/A
- P/E Ratio
- RADX N/A
- STEC N/A
- Revenue Growth
- RADX N/A
- STEC N/A
- 52 Week Low
- RADX $3.50
- STEC $0.20
- 52 Week High
- RADX $50.82
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- STEC 38.03
- Support Level
- RADX N/A
- STEC $0.70
- Resistance Level
- RADX N/A
- STEC $0.80
- Average True Range (ATR)
- RADX 0.00
- STEC 0.08
- MACD
- RADX 0.00
- STEC 0.00
- Stochastic Oscillator
- RADX 0.00
- STEC 34.03
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.